Your institution may have access to this item. Find your institution then sign in to continue.
Title
People.
Abstract
The article focuses on several personnel changes in the U.S. biopharmaceutical industry including Drew Fromkin as board of director of Regado Biosciences, Lars Ekman at Spark Therapeutics and Ronald Nardi at Scioderm.